866-997-4948(US-Canada Toll Free)

Companion Animal Vaccines Market: Canine Segment Anticipated to Retain Its Dominance Throughout the Forecast Period: Global Industry Analysis and Opportunity Assessment, 2016-2026

Published By :

Future Market Insights

Published Date : Mar 2017

Category :

Vaccines

No. of Pages : 220 Pages

Companion animal vaccines are used to stimulate an immune response in pets such as canine, avian and feline. These vaccine products are of various types such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines. Attenuated live vaccines are derived from disease-causing pathogens such as virus or bacteria, which have been weakend under laboratory conditions. Conjugate vaccines are an antigen or toxoid-containing preparation that is linked to polysaccharides and stimulate the immature immune system to defend against the disease-causing organism. Inactivated vaccines are made from microorganisms such as viruses and bacteria that have been killed through physical or chemical processes. Subunit vaccines, like inactivated whole-cell vaccines, do not contain live components of the pathogen. Toxoid vaccines are based on the toxin produced by certain bacteria, which is rendered harmless and used as the antigen in the vaccine to elicit an immune response. DNA vaccines are manufactured by inserting DNA into a bacterial plasmid, which functions as the vector. Recombinant vaccines are produced by genetic engineering technology and use attenuated virus or bacterium as a vector to introduce microbial DNA to the cells of the body.

The global companion animal vaccines market was valued at more than US$ 2,100 Mn in 2015 and is projected to register a CAGR of 6.8% during the forecast period. The market is expected to be valued at nearly US$ 4,500 Mn by the end of 2026.

Global Companion Animal Vaccines Market Forecast, By Species Type, 20162026

The Canine species segment is anticipated to register a 6.9% CAGR over the forecast period and be valued at nearly US$ 2,500 Mn by 2026 end. The Canine species segment was estimated to account for 50.9% share of the global companion animal vaccines market by 2016 end. Whereas the Avian species segment was estimated to account for 14.1% value share of the global companion animal vaccines market by 2016 end.

Global Companion Animal Vaccines Market Attractiveness Analysis, By Species Type, 20162026

The Canine segment dominated the global companion animal vaccines market in revenue terms in 2016 and is projected to continue to do so throughout the forecast period. The Canine segment is the most attractive segment, recording an attractiveness index of 1.5 over the forecast period. The segment is projected to account for 51.0% value share by 2026 end. The Feline segment is expected to be the second most lucrative segment in the with an attractiveness index of 1.1 during the forecast period.

global companion animal vaccines market

Market consolidation in developed regions could ease product availability

Mergers and acquisitions are gaining a wider footprint within the global companion animal vaccines market in developed regions, which is expected to widen product availability and ease market access. For example, global veterinary product manufacturer Elanco has agreed to buy Boehringer Ingelheim Vetmedica Inc.s U.S. companion animal vaccines business apart from Fort Dodge manufacturing facility as of October 2016. Besides strengthening Elancos market position in the global animal health business, the company also plans to boost vaccine research and testing in collaboration with veterinarians.

Rising adoption of pets is fuelling the global companion animal vaccines market

Increasing humanisation of pets and adoption in developed markets such as the U.S. is driving the demand for animal vaccines. Furthermore, growing trend of using pets as a status symbol in many countries is also expected to fuel the markets revenue growth. Pets are known to provide relief from psychological stress emanating from solitary nuclear family structures, prevalent across most developed and rapidly emerging markets. To exemplify, data from the American Pet Products Association noted that as of 2016, 70 million to 80 million dogs (approximately 37% to 47% of all households) and 74 million to 96 million cats (30% to 37% of all households) are owned in the U.S.

-- Analyst Healthcare, Pharmaceuticals and Medical Devices, Future Market Insights

Table Of Content


1. Executive Summary


2. Market Introduction
2.1. Companion Animal Vaccines Market Definition
2.2. Companion Animal Vaccines Market Taxonomy
2.3. Veterinary Vaccines Market


3. Companion Animal Vaccines Market Analysis Scenario
3.1. Regulations and Reimbursement Scenario
3.2. Global Company Market Share Analysis (2015)
3.3. Mechanism for Veterinary Product Approval
3.4. Companion Animal Vaccines Market Overview
3.4.1. List of Active Participants


4. Companion Animal Vaccines Market Dynamics
4.1. Macro-economic Factors
4.2. Drivers
4.2.1. Supply Side
4.2.2. Demand Side
4.3. Restraints
4.4. Opportunity
4.5. Global Trends


5. Global Companion Animal Vaccines Market Analysis and Forecast, By Product Type
5.1. Introduction
5.1.1. Basis Point Share (BPS) Analysis By Product Type
5.1.2. Y-o-Y Growth Projections By Product Type
5.2. Market Size (US$ Mn) Forecast By Product Type
5.2.1. Attenuated Live Vaccines
5.2.2. Conjugate Vaccines
5.2.3. Inactivated Vaccines
5.2.4. Subunit Vaccines
5.2.5. Toxoid Vaccines
5.2.6. DNA Vaccines
5.2.7. Recombinant Vaccines
5.3. Market Attractiveness Analysis By Product Type
5.4. Prominent Trends


6. Global Companion Animal Vaccines Market Analysis and Forecast, By Distribution Channel
6.1. Introduction
6.1.1. Basis Point Share (BPS) Analysis By Distribution Channel
6.1.2. Y-o-Y Growth Projections By Distribution Channel
6.1.3. Comparative Analysis By Distribution Channel
6.2. Market Size (US$ Mn) Forecast By Distribution Channel
6.2.1. Veterinary Clinics
6.2.2. Veterinary Hospitals
6.2.3. Veterinary Research Institutes
6.2.4. Retail Pharmacies & Others
6.3. Market Attractiveness Analysis By Distribution Channel
6.4. Prominent Trends


7. Global Companion Animal Vaccines Market Analysis and Forecast, By Species Type
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis By Species Type
7.1.2. Y-o-Y Growth Projections By Species Type
7.1.3. Comparative Analysis By Species Type
7.2. Market Size (US$ Mn) Forecast By Species Type
7.2.1. Canine
7.2.2. Avian
7.2.3. Feline
7.3. Market Attractiveness Analysis By Species Type


8. Global Companion Animal Vaccines Market Analysis and Forecast, By Region
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis By Region
8.1.2. Y-o-Y Growth Projections By Region
8.2. Market Size (US$ Mn) Forecast By Region
8.2.1. North America
8.2.2. Latin America
8.2.3. Western Europe
8.2.4. Eastern Europe
8.2.5. Asia Pacific Excl. Japan (APEJ)
8.2.6. Japan
8.2.7. Middle East and Africa (MEA)
8.3. Market Attractiveness Analysis By Region


9. North America Companion Animal Vaccines Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis By Country
9.1.2. Y-o-Y Growth Projections By Country
9.1.3. Key Regulations
9.2. Market Size (US$ Mn) Forecast By Country
9.2.1. U.S.
9.2.2. Canada
9.3. Market Size (US$ Mn) Forecast By Product Type
9.3.1. Attenuated Live Vaccines
9.3.2. Conjugate Vaccines
9.3.3. Inactivated Vaccines
9.3.4. Subunit Vaccines
9.3.5. Toxoid Vaccines
9.3.6. DNA Vaccines
9.3.7. Recombinant Vaccines
9.4. Market Size (US$ Mn) Forecast By Distribution Channel
9.4.1. Veterinary Clinics
9.4.2. Veterinary Hospitals
9.4.3. Veterinary Research Institutes
9.4.4. Retail Pharmacies & Others
9.5. Market Size (US$ Mn) Forecast By Species Type
9.5.1. Canine
9.5.2. Avian
9.5.3. Feline
9.6. Market Attractiveness Analysis
9.6.1. By Country
9.6.2. By Product Type
9.6.3. By Distribution Channel
9.6.4. By Species Type


10. Latin America Companion Animal Vaccines Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis By Country
10.1.2. Y-o-Y Growth Projections By Country
10.1.3. Key Regulations
10.2. Market Size (US$ Mn) and Volume (Units) Forecast By Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Market Size (US$ Mn) Forecast By Product Type
10.3.1. Attenuated Live Vaccines
10.3.2. Conjugate Vaccines
10.3.3. Inactivated Vaccines
10.3.4. Subunit Vaccines
10.3.5. Toxoid Vaccines
10.3.6. DNA Vaccines
10.3.7. Recombinant Vaccines
10.4. Market Size (US$ Mn) Forecast By Distribution Channel
10.4.1. Veterinary Clinics
10.4.2. Veterinary Hospitals
10.4.3. Veterinary Research Institutes
10.4.4. Retail Pharmacies & Others
10.5. Market Size (US$ Mn) Forecast By Species Type
10.5.1. Canine
10.5.2. Avian
10.5.3. Feline
10.6. Market Attractiveness Analysis
10.6.1. By Country
10.6.2. By Product Type
10.6.3. By Distribution Channel
10.6.4. By Species Type


11. Western Europe Companion Animal Vaccines Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis By Country / Region
11.1.2. Y-o-Y Growth Projections By Country
11.1.3. Key Regulations
11.2. Market Size (US$ Mn) and Volume (Units) Forecast By Country / Region
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. Spain
11.2.5. U.K.
11.2.6. BENELUX
11.2.7. Rest of Western Europe
11.3. Market Size (US$ Mn) Forecast By Product Type
11.3.1. Attenuated Live Vaccines
11.3.2. Conjugate Vaccines
11.3.3. Inactivated Vaccines
11.3.4. Subunit Vaccines
11.3.5. Toxoid Vaccines
11.3.6. DNA Vaccines
11.3.7. Recombinant Vaccines
11.4. Market Size (US$ Mn) Forecast By Distribution Channel
11.4.1. Veterinary Clinics
11.4.2. Veterinary Hospitals
11.4.3. Veterinary Research Institutes
11.4.4. Retail Pharmacies & Others
11.5. Market Size (US$ Mn) Forecast By Species Type
11.5.1. Canine
11.5.2. Avian
11.5.3. Feline
11.6. Market Attractiveness Analysis
11.6.1. By Country
11.6.2. By Product Type
11.6.3. By Distribution Channel
11.6.4. By Species Type


12. Eastern Europe Companion Animal Vaccines Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis By Country
12.1.2. Y-o-Y Growth Projections By Country
12.1.3. Key Regulations
12.2. Market Size (US$ Mn) and Volume (Units) Forecast By Country
12.2.1. Russia
12.2.2. Poland
12.2.3. Rest of Eastern Europe
12.3. Market Size (US$ Mn) Forecast By Product Type
12.3.1. Attenuated Live Vaccines
12.3.2. Conjugate Vaccines
12.3.3. Inactivated Vaccines
12.3.4. Subunit Vaccines
12.3.5. Toxoid Vaccines
12.3.6. DNA Vaccines
12.3.7. Recombinant Vaccines
12.4. Market Size (US$ Mn) Forecast By Distribution Channel
12.4.1. Veterinary Clinics
12.4.2. Veterinary Hospitals
12.4.3. Veterinary Research Institutes
12.4.4. Retail Pharmacies & Others
12.5. Market Size (US$ Mn) Forecast By Species Type
12.5.1. Canine
12.5.2. Avian

 

List of Table

Table 1: Global Companion Animal Vaccines Market Value Forecast, By Product Type, 2016–2026 (US$ Mn)
Table 2: Global Companion Animal Vaccines Market Value Forecast, By Distribution Channel, 2016–2026 (US$ Mn)
Table 3: Global Companion Animal Vaccines Market Value Forecast, By Species Type, 2016–2026 (US$ Mn)
Table 4: Global Companion Animal Vaccines Market Value (US$ Mn) Forecast, By Region, 2016–2026
Table 5: North America Companion Animal Vaccine Market Value (US$ Mn) Forecast, By Product Type, 2016–2026
Table 6: North America Companion Animal Vaccine Market Value (US$ Mn) Forecast, By Distribution Channel, 2016–2026
Table 7: North America Companion Animal Vaccine Market Value Forecast, By Species Type, 2016–2026 (US$ Mn)
Table 8: North America Companion Animal Vaccine Market Value Forecast, By Country, 2016–2026 (US$ Mn)
Table 9: Latin America Companion Animal Vaccine Market Value (US$ Mn) Forecast, By Product Type, 2016–2026
Table 10: Latin America Companion Animal Vaccine Market Value (US$ Mn) Forecast, By Distribution Channel, 2016–2026
Table 11: Latin America Companion Animal Vaccine Market Value (US$ Mn) Forecast, By Species Type, 2016–2026
Table 12: Latin America Companion Animal Vaccine Market Value (US$ Mn) Forecast, By Country, 2016–2026
Table 13: Western Europe Companion Animal Vaccine Market Value(US$ Mn) Forecast, By Product Type, 2016–2026
Table 14: Western Europe Companion Animal Vaccine Market Value (US$ Mn) Forecast, By Distribution Channel, 2016–2026
Table 15: Western Europe Companion Animal Vaccine Market Value (US$ Mn) Forecast, By Species Type, 2016–2026
Table 16: Western Europe Companion Animal Vaccine Market Value (US$ Mn) Forecast, By Country, 2016–2026
Table 17: Eastern Europe Companion Animal Vaccine Market Value(US$ Mn) Forecast, By Product Type, 2016–2026
Table 18: Eastern Europe Companion Animal Vaccine Market Value (US$ Mn) Forecast, By Distribution Channel, 2016–2026
Table 19: Eastern Europe Companion Animal Vaccine Market Value (US$ Mn) Forecast, By Species Type, 2016–2026
Table 20: Eastern Europe Companion Animal Vaccine Market Value (US$ Mn) Forecast, By Country, 2016–2026
Table 21: APEJ Companion Animal Vaccine Market Value (US$ Mn) Forecast, By Product Type, 2016–2026
Table 22: APEJ Companion Animal Vaccine Market Value (US$ Mn) Forecast, By Distribution Channel, 2016–2026
Table 23: APEJ Companion Animal Vaccine Market Value (US$ Mn) Forecast, By Species Type, 2016–2026
Table 24: APEJ Companion Animal Vaccine Market Value (US$ Mn) Forecast, By Country, 2016–2026
Table 25: Japan Companion Animal Vaccine Market Value (US$ Mn) Forecast, By Product Type, 2016–2026
Table 26: Japan Companion Animal Vaccine Market Value (US$ Mn) Forecast, By Distribution Channel, 2016–2026
Table 27: Japan Companion Animal Vaccine Market Value (US$ Mn) Forecast, By Species Type, 2016–2026
Table 28: MEA Companion Animal Vaccine Market Value (US$ Mn) Forecast, By Product Type, 2016–2026
Table 29: MEA Companion Animal Vaccine Market Value (US$ Mn) Forecast, By Distribution Channel, 2016–2026
Table 30: MEA Companion Animal Vaccine Market Value (US$ Mn) Forecast, By Species Type, 2016–2026
Table 31: MEA Companion Animal Vaccine Market Value (US$ Mn) Forecast, By Country, 2016–2026

List of Chart

Figure 1: Global Companion Animal Vaccine Market Share, by Species Type, 2016 (E)
Figure 2: Global Companion Animal Vaccine Market Share, by Product Type, 2016 (E)
Figure 3: Global Companion Animal Vaccine Market Share, by Distribution Channel, 2016 (E)
Figure 4: Market Share of Prominent Key Players: Companion Animal Vaccine Market, 2015
Figure 5 : Global Companion Animal Vaccines Share Analysis (%) By Product Type, 2016 & 2026
Figure 6 : Global Companion Animal Vaccines Y-o-Y growth (%) By Product Type, 2016–2026
Figure 7: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) By Attenuated Live Vaccines, 2016–2026
Figure 8: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) By Conjugate Vaccines , 2016–2026
Figure 9: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) By Inactivated Vaccines, 2016–2026
Figure 10: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) By Subunit Vaccines, 2016–2026
Figure 11: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) By Toxoid Vaccines, 2016–2026
Figure 12: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) By DNA Vaccines, 2016–2026
Figure 13: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) By Recombinant Vaccines, 2016–2026
Figure 14: Global Companion Animal Vaccines Market Attractiveness Analysis, by Product Type, 2016–2026
Figure 15 : Global Companion Animal Vaccines Share Analysis (%) By Distribution Channel, 2016 & 2026
Figure 16 : Global Companion Animal Vaccines Y-o-Y growth (%) By Distribution Channel, 2016–2026
Figure 17: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) Veterinary Clinics, 2016–2026
Figure 18: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) By Veterinary Hospitals, 2016–2026
Figure 19: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) Veterinary Research Institutes, 2016–2026
Figure 20: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) By Retail Pharmacies, 2016–2026
Figure 21: Global Companion Animal Vaccines Market Attractiveness Analysis, by Distribution Channel, 2016–2026
Figure 22 : Global Companion Animal Vaccines Share Analysis (%) By Species Type, 2016 & 2026
Figure 23 : Global Companion Animal Vaccines Y-o-Y growth (%) By Species Type, 2015–2026
Figure 24: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) Canine, 2016–2026
Figure 25: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) By Avian, 2016–2026
Figure 26: Global Companion Animal Vaccines Market Absolute $ Opportunity (US$ Mn) Feline, 2016–2026
Figure 27: Global Companion Animal Vaccines Market Attractiveness Analysis, By Species Type, 2016–2026
Figure 28 : Global Companion Animal Vaccines Share Analysis (%) By Region, 2016 & 2026
Figure 29 : Global Companion Animal Vaccines Share Analysis (%) By Region, 2016 & 2026
Figure 30: Global Companion Animal Vaccines Market Attractiveness Analysis, By Region, 2016–2026
Figure 31 : North America Companion Animal Vaccine Share Analysis (%) By Product Type, 2016 & 2026
Figure 32 : North America Companion Animal Vaccine Y-o-Y growth (%) By Product Type, 2016–2026
Figure 33: North America Companion Animal Vaccine Market Attractiveness Analysis, by Product Type, 2016–2026
Figure 34 : North America Companion Animal Vaccine Share Analysis (%) By Distribution Channel, 2016 & 2026
Figure 35 : North America Companion Animal Vaccine Y-o-Y growth (%) By Distribution Channel, 2015–2026
Figure 36: North America Companion Animal Vaccine Market Attractiveness Analysis, by Distribution Channel, 2016–2026
Figure 37 : North America Companion Animal Vaccine Share Analysis (%) By Species Type, 2016 & 2026
Figure 38 : North America Companion Animal Vaccine Y-o-Y growth (%) By Species Type, 2015–2026
Figure 39: North America Companion Animal Vaccine Market Attractiveness Analysis, By Species Type, 2016–2026
Figure 40 : North America Companion Animal Vaccine Share Analysis (%) By Country, 2016 & 2026
Figure 41: North America Companion Animal Vaccine Y-o-Y growth (%) By Country, 2015–2026
Figure 42: North America Companion Animal Vaccine Market Attractiveness Analysis, By Country, 2016–2026
Figure 43 : Latin America Companion Animal Vaccine Share Analysis (%) By Product Type, 2016 & 2026
Figure 44 : Latin America Companion Animal Vaccine Y-o-Y growth (%) By Product Type, 2016–2026
Figure 45: Latin America Companion Animal Vaccine Market Attractiveness Analysis, by Product Type, 2016–2026
Figure 46 : Latin America Companion Animal Vaccine Share Analysis (%) By Distribution Channel, 2016 & 2026
Figure 47 : Latin America Companion Animal Vaccine Y-o-Y growth (%) By Distribution Channel, 2015–2026
Figure 48: Latin America Companion Animal Vaccine Market Attractiveness Analysis, by Distribution Channel, 2016–2026
Figure 49 : Latin America Companion Animal Vaccine Share Analysis (%) By Species Type, 2016 & 2026
Figure 50 : Latin America Companion Animal Vaccine Y-o-Y growth (%) By Species Type, 2015–2026
Figure 51: Latin America Companion Animal Vaccine Market Attractiveness Analysis, By Species Type, 2016–2026
Figure 52 : Latin America Companion Animal Vaccine Share Analysis (%) By Country, 2016 & 2026
Figure 53 : Latin America Companion Animal Vaccine Y-o-Y growth (%) By Country, 2015–2026
Figure 54: Latin America Companion Animal Vaccine Market Attractiveness Analysis, By Country, 2016–2026
Figure 55 : Western Europe Companion Animal Vaccine Share Analysis (%) By Product Type, 2016 & 2026
Figure 56 : Western Europe Companion Animal Vaccine Y-o-Y growth (%) By Product Type, 2016–2026
Figure 57: Western Europe Companion Animal Vaccine Market Attractiveness Analysis, by Product Type, 2016–2026
Figure 58 : Western Europe Companion Animal Vaccine Share Analysis (%) By Distribution Channel, 2016 & 2026
Figure 59 : Western Europe Companion Animal Vaccine Y-o-Y growth (%) By Distribution Channel, 2015–2026
Figure 60: Western Europe Companion Animal Vaccine Market Attractiveness Analysis, by Distribution Channel, 2016–2026
Figure 61 : Western Europe Companion Animal Vaccine Share Analysis (%) By Species Type, 2016 & 2026
Figure 62 : Western Europe Companion Animal Vaccine Y-o-Y growth (%) By Species Type, 2016–2026
Figure 63: Western Europe Companion Animal Vaccine Market Attractiveness Analysis, By Species Type, 2016–2026
Figure 64 : Western Europe Companion Animal Vaccine Share Analysis (%) By Country, 2016 & 2026
Figure 65 : Western Europe Companion Animal Vaccine Y-o-Y growth (%) By Country, 2016–2026
Figure 66: Western Europe Companion Animal Vaccine Market Attractiveness Analysis, By Country, 2016–2026
Figure 67 : Eastern Europe Companion Animal Vaccine Share Analysis (%) By Product Type, 2016 & 2026
Figure 68 : Eastern Europe Companion Animal Vaccine Y-o-Y growth (%) By Product Type, 2015–2026
Figure 69: Eastern Europe Companion Animal Vaccine Market Attractiveness Analysis, by Product Type, 2016–2026
Figure 70 : Eastern Europe Companion Animal Vaccine Share Analysis (%) By Distribution Channel, 2016 & 2026
Figure 71: Eastern Europe Companion Animal Vaccine Y-o-Y growth (%) By Distribution Channel, 2015–2026
Figure 72: Eastern Europe Companion Animal Vaccine Market Attractiveness Analysis, by Distribution Channel, 2016–2026
Figure 73 : Eastern Europe Companion Animal Vaccine Share Analysis (%) By Species Type, 2016 & 2026
Figure 74 : Eastern Europe Companion Animal Vaccine Y-o-Y growth (%) By Species Type, 2015–2026
Figure 75: Eastern Europe Companion Animal Vaccine Market Attractiveness Analysis, By Species Type, 2016–2026
Figure 76 : Eastern Europe Companion Animal Vaccine Share Analysis (%) By Country, 2016 & 2026
Figure 77 : Eastern Europe Companion Animal Vaccine Y-o-Y growth (%) By Country, 2015–2026
Figure 78: Eastern Europe Companion Animal Vaccine Market Attractiveness Analysis, By Country, 2016–2026
Figure 79 : APEJ Companion Animal Vaccine Share Analysis (%) By Product Type, 2016 & 2026
Figure 80 : APEJ Companion Animal Vaccine Y-o-Y growth (%) By Product Type, 2016–2026
Figure 81 : APEJ Companion Animal Vaccine Market Attractiveness Analysis, by Product Type, 2016–2026
Figure 82 : APEJ Companion Animal Vaccine Share Analysis (%) By Distribution Channel, 2016 & 2026
Figure 83 : APEJ Companion Animal Vaccine Y-o-Y growth (%) By Distribution Channel, 2015–2026
Figure 84: APEJ Companion Animal Vaccine Market Attractiveness Analysis, by Distribution Channel, 2016–2026
Figure 85 : APEJ Companion Animal Vaccine Share Analysis (%) By Species Type, 2016 & 2026
Figure 86 : APEJ Companion Animal Vaccine Y-o-Y growth (%) By Species Type, 2015–2026
Figure 87: APEJ Companion Animal Vaccine Market Attractiveness Analysis, By Species Type, 2016–2026
Figure 88 : APEJ Companion Animal Vaccine Share Analysis (%) By Country, 2016 & 2026
Figure 89 : APEJ Companion Animal Vaccine Y-o-Y growth (%) By Country, 2015–2026
Figure 90: APEJ Companion Animal Vaccine Market Attractiveness Analysis, By Country, 2016–2026
Figure 91: Japan Companion Animal Vaccine Share Analysis (%) By Product Type, 2016 & 2026
Figure 92 : Japan Companion Animal Vaccine Y-o-Y growth (%) By Product Type, 2015–2026
Figure 93: Japan Companion Animal Vaccine Market Attractiveness Analysis, by Product Type, 2016–2026
Figure 94: Japan Companion Animal Vaccine Share Analysis (%) By Distribution Channel, 2016 & 2026
Figure 95: Japan Companion Animal Vaccine Y-o-Y growth (%) By Distribution Channel, 2015–2026
Figure 96: Japan Companion Animal Vaccine Market Attractiveness Analysis, by Distribution Channel, 2016–2026
Figure 97 : Japan Companion Animal Vaccine Share Analysis (%) By Species Type, 2016 & 2026
Figure 98 : Japan Companion Animal Vaccine Y-o-Y growth (%) By Species Type, 2015–2026
Figure 99: Japan Companion Animal Vaccine Market Attractiveness Analysis, By Species Type, 2016–2026
Figure 100: MEA Companion Animal Vaccine Share Analysis (%) By Product Type, 2016 & 2026
Figure 101 : MEA Companion Animal Vaccine Y-o-Y growth (%) By Product Type, 2015–2026
Figure 102: MEA Companion Animal Vaccine Market Attractiveness Analysis, by Product Type, 2016–2026
Figure 103: MEA Companion Animal Vaccine Share Analysis (%) By Distribution Channel, 2016 & 2026
Figure 104: MEA Companion Animal Vaccine Y-o-Y growth (%) By Distribution Channel, 2015–2026
Figure 105: MEA Companion Animal Vaccine Market Attractiveness Analysis, by Distribution Channel, 2016–2026
Figure 106: MEA Companion Animal Vaccine Share Analysis (%) By Species Type, 2016 & 2026
Figure 107 : MEA Companion Animal Vaccine Y-o-Y growth (%) By Species Type, 2015–2026
Figure 108: MEA Companion Animal Vaccine Market Attractiveness Analysis, By Species Type, 2016–2026
Figure 109: MEA Companion Animal Vaccine Share Analysis (%) By Country/Region, 2016 & 2026
Figure 110: MEA Companion Animal Vaccine Y-o-Y growth (%) By Country/Region, 2015–2026
Figure 111: MEA Companion Animal Vaccine Market Attractiveness Analysis, By Country/Region, 2016–2026

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *